Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine

NCT02745392 is registered in ClinicalTrials.gov with Zosano Pharma Corporation as lead sponsor.

NCT NCT02745392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02745392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Lead sponsor
Zosano Pharma Corporation
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2016
Completion date
January 31, 2017
Enrollment
365 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

acute migraine